Baseline characteristics

CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia · Source last updated 2014-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      32

   2. group Id

      BG001

      value

      39

   3. group Id

      BG002

      value

      18

   4. group Id

      BG003

      value

      89

   units

   Participants

groups

1. description

   Patients received Temsirolimus (CCI-779) IV over 30 minutes on days 1,8,15, and 22. Courses repeated every 28 days in the absence of disease progression or unacceptable toxicity. Patients were followed every 8 weeks. Aggressive B-cell lymphoma group was defined as patients with histologic subtypes included diffuse large B-cell lymphoma and transformed follicular lymphoma.

   id

   BG000

   title

   Aggressive B-cell Lymphoma

2. description

   Patients received Temsirolimus (CCI-779) IV over 30 minutes on days 1,8,15, and 22. Courses repeated every 28 days in the absence of disease progression or unacceptable toxicity. Patients were followed every 8 weeks. Follicular lymphoma group was defined as patients with histologic subtypes included follicular lymphoma.

   id

   BG001

   title

   Follicular Lymphoma

3. description

   Patients received Temsirolimus (CCI-779) IV over 30 minutes on days 1,8,15, and 22. Courses repeated every 28 days in the absence of disease progression or unacceptable toxicity. Patients were followed every 8 weeks. Chronic lymphocytic leukemia group was defined as patients with histologic subtypes included chronic lymphocytic leukemia, small lymphocytic lymphoma, and other indolent lymphomas.

   id

   BG002

   title

   Chronic Lymphocytic Leukemia

4. description

   Total of all reporting groups

   id

   BG003

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            lower Limit

            30

            upper Limit

            87

            value

            67

         2. group Id

            BG001

            lower Limit

            28

            upper Limit

            75

            value

            59

         3. group Id

            BG002

            lower Limit

            38

            upper Limit

            82

            value

            57

         4. group Id

            BG003

            lower Limit

            28

            upper Limit

            87

            value

            61

   dispersion Type

   FULL_RANGE

   param Type

   MEDIAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            15

         2. group Id

            BG001

            value

            15

         3. group Id

            BG002

            value

            7

         4. group Id

            BG003

            value

            37

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            17

         2. group Id

            BG001

            value

            24

         3. group Id

            BG002

            value

            11

         4. group Id

            BG003

            value

            52

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice